Touyun Biotech Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 27.52 | -100% | -13.49 | -100% |
| P/S |
|
3.42 | 2.26 | 51.12% |
|
|
| P/BV |
|
32.22 | -89.5 | -136% |
|
|
| P/FCF |
|
-120.86 | 139.91 | -186.38% |
|
|
| Ev/Ebitda |
|
-9.71 | 24.02 | -140.43% |
|
|
| Ev/S |
|
5.04 | 3.52 | 43.06% |
|
|
| Ev/FCF |
|
-74.21 | 111.16 | -166.76% |
|
|
| E/P |
|
-0.165 | 0.0427 | -486.19% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-72.69 | 19.47 | -473.4% | -26.42 | +175.2% |
| ROE |
|
-204.43 | 0.92 | -22319.48% |
|
|
| ROA |
|
-35.98 | 4.29 | -939.46% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-135.39 | 15.02 | -1001.39% |
|
|
| ROCE |
|
0 | 2.74 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-3.47 | 4.82 | -172.14% | 9.13 | -138.03% |
| Nеt Debt/Ebitda |
|
-2.23 | 2.8 | -179.54% |
|
|
| Debt/Ratio |
|
0.8259 | 0.2308 | 257.8% |
|
|
| Debt/Equity |
|
1.32 | 0.9787 | 34.42% |
|
|
| Debt/Net Income |
|
-1.87 | 5.87 | -131.78% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.63 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.27 | -100% | ||
| DSI |
|
0 | 0.7748 | -100% |
|
|
| Average dividend growth |
|
0 | -8.4 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.02 | -100% |
|
|
| Average percentage for payments |
|
0 | 35.85 | -100% |
|
|
| Difference from average difference in sector |
|
-5.63 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-39.8 | 135.32 | -129.41% | ||
| Growth impulse Ebitda in 5 years |
|
-59.56 | -49.93 | 19.29% | ||
| Growth impulse Net Income in 5 years |
|
34.13 | 202.35 | -83.13% | ||
| Growth impulse FCF in 5 years |
|
-84.6 | 344.45 | -124.56% | ||
| Growth impulse EPS in 5 years |
|
19.81 | 260.48 | -92.39% |
IP Score
2.68/10
